Nonscheduled Qelbree can be tailored to help meet your patient’s needs.
Straightforward, easy administration1
Capsules can be swallowed whole, or capsule can be opened and its entire contents sprinkled onto a teaspoonful of applesauce and all consumed within two hours.1,2
Note: Capsules and their contents should not be cut, crushed, or chewed.1
3 strengths allow for flexible dosing1
Qelbree capsules are available in 3 dosage strengths: 100-mg capsules, 150-mg capsules, and 200-mg capsules.1
Capsules shown are not actual size.
Qelbree follows a clear titration schedule1
Children 6 to 111
The recommended dose for pediatric patients 6-11 years of age is 100-400 mg orally, once daily.1 Titrate Qelbree 100 mg per week as needed to reach effective dose based on response and tolerability.1
Adolescents 12 to 171
The recommended dose for adolescent patients 12-17 years of age is 200-400 mg orally, once daily.1 Titrate Qelbree 200 mg per week over 1 week as needed to reach effective dose based on response and tolerability.1
Maximum dose for children and adolescents is 400 mg daily.
Dosing safety information1
- Swallow Qelbree capsules whole or sprinkle entire contents onto a teaspoonful of applesauce and consume all within 2 hours, without regard to meals. Do not cut, crush, or chew the capsules.
- Severe renal impairment: Initiate Qelbree at 100 mg and increase by 50 mg to 100 mg at weekly intervals to a maximum recommended dosage of 200 mg once daily
- Qelbree is a strong CYP1A2 inhibitor. Coadministration with moderately sensitive CYP1A2 substrates (eg, clozapine and pirfenidone) is not recommended. If coadministered, dose reduction may be warranted
- Qelbree is a weak inhibitor of CYP2D6 and CYP3A4, which increases exposure of those substrates (eg, dextromethorphan and alfentanil) when coadministered with Qelbree. Monitor patients for adverse reactions and adjust dosages of substrates, as clinically indicated
Refills without a new prescription every month
Qelbree, a nonscheduled therapy, offers symptom improvement across several phase III clinical trials.2
You may even be able to prescribe a 90-day supply for more convenience.*
*Subject to any plan restrictions.